Atlas Trials

Evaluation of dAroLutamide Addition to anDrogen Deprivation Therapy and radIatioN Therapy in Newly Diagnosed Prostate Cancer With Pelvic Lymph Nodes Metastases

Clinical trial NCT05116475 · RECRUITING

Trial details

NCT number
NCT05116475
Sponsor
Association Pour La Recherche des Thérapeutiques Innovantes en Cancérologie
Status
RECRUITING
Phase
Phase 3
Study type
INTERVENTIONAL
Prostate Cancer
Start date
2022-08-30
Primary completion
2026-02-01
Enrollment
152

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.